日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multiomic Characterization of Pre- and Post-Neoadjuvant Chemotherapy-Treated Ovarian Cancer Reveals Mediators of Tumorigenesis and Chemotherapy Response

新辅助化疗前后卵巢癌的多组学特征分析揭示了肿瘤发生和化疗反应的介质

Valentine, Mark C; Mullen, Mary M; Kotnik, Emilee N; Powell, Matthew A; Thaker, Premal H; McCourt, Carolyn K; Kuroki, Lindsay M; Hagemann, Andrea R; Arend, Rebecca C; Holehouse, Alex S; Mitra, Robi; Mutch, David G; Fuh, Katherine C

Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity.

抗体和 CAR 介导的巨噬细胞毒性的可利用机制

Liu Tianyi, Zhang Meng, Farsh Tatyanah, Li Haolong, Kishishita Audrey, Barpanda Abhilash, Leung Stanley G, Zhu Jun, Jung Hyuncheol, Hua Junjie Tony, Zhu Xiaolin, Kim Alexander B, Goo Young Ah, Son Minsoo, Kim Jaenyeon, Subramanian Aish, Sjöström Martin, Fuh Katherine C, Chapman Jocelyn S, Carnevale Julia, Gilbert Luke A, Lakkaraju Aparna, Bruno Peter M, Quigley David, Wiita Arun P, Feng Felix Y, DeSelm Carl J

Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer.

磷酸化RPA2可预测同源重组功能正常的卵巢癌对铂类和PARP抑制剂的反应

Schab Angela, Compadre Amanda, Drexler Rebecca, Loeb Megan, Rodriguez Kevin, Brill Joshua, Harrington Shariska, Sandoval Carmen, Sanders Brooke, Kuroki Lindsay, McCourt Carolyn, Hagemann Andrea R, Thaker Premal, Mutch David, Powell Matthew, Serra Violeta, Hagemann Ian S, Walts Ann E, Karlan Beth Y, Orsulic Sandra, Fuh Katherine C, Sun Lulu, Verma Priyanka, Lomonosova Elena, Zhao Peinan, Khabele Dineo, Mullen Mary M

Delay to timely treatment in locally advanced cervical cancer: insurance inequities in access to gynecologic oncology

局部晚期宫颈癌治疗延误:妇科肿瘤治疗中保险不平等现象

Liang, Jessica; Mvemba, Audrey; Swanson, Megan; Hsu, I-Chow Joe; Alvarez, Edwin; Chapman, Jocelyn; Fuh, Katherine; Chen, Lee-May; Cham, Stephanie

DDR2 Confers Ferroptosis Resistance to Cancer-Associated Fibroblasts and Attenuates PARPi Sensitivity of Ovarian Tumor Cells

DDR2赋予癌相关成纤维细胞铁死亡抵抗力,并减弱卵巢肿瘤细胞对PARP抑制剂的敏感性

Lesage, Julien; DiMauro, Alessandra; Schab, Angela M; Stidham, Seth; Mullen, Mary M; Fuh, Katherine C; Longmore, Gregory D

Fragmented Care and Guideline-Concordant Treatment in Locally Advanced Cervical Cancer

局部晚期宫颈癌的碎片化治疗与指南一致性治疗

Mvemba, Audrey; Liang, Jessica; Swanson, Megan; Yoshida, Emi; Ueda, Stefanie; Fuh, Katherine; Chen, Lee-May; Cham, Stephanie

New opportunities for opportunistic salpingectomy: Leveraging non-gynecologic surgeries for ovarian cancer prevention

机会性输卵管切除术的新契机:利用非妇科手术预防卵巢癌

Guo, X Mona; Fuh, Katherine C; Stone, Rebecca

Complete response of somatic POLE-ultramutated recurrent undifferentiated uterine sarcoma to pembrolizumab and concurrent radiotherapy

体细胞 POLE 超突变复发性未分化子宫肉瘤对帕博利珠单抗联合放疗完全缓解

Charewycz, Natasha E; Hsu, I-Chow Joe; Lu, Kevin; Fuh, Katherine; Chen, Lee-May; Monga, Varun; Cham, Stephanie

Considering homologous recombination deficiency status in HIPEC: could molecular testing someday drive "targeted" surgery?

考虑 HIPEC 中的同源重组缺陷状态:分子检测未来能否指导“靶向”手术?

Huepenbecker, Sarah P; Fuh, Katherine C

Targeting the COP9 signalosome overcomes platinum resistance in ovarian cancer through two distinct genome stability mechanisms

靶向 COP9 信号体可通过两种不同的基因组稳定性机制克服卵巢癌的铂类耐药性。

Lomonosova, Elena; Loeb, Megan; Rodriguez, Kevin; van Biljon, Lilian N; Brill, Joshua; Schab, Angela; Minett, Margaret; Barron, Jaeden; Bittner, Maya; Park, Jiyoung; Drexler, Rebecca; Sandoval, Carmen; Oplt, Alyssa; Gallup, Eden; Thuthika, Prasanth K; Sadeghipour, Negar; Wu, Sharon; Oberley, Matthew J; Sanders, Brooke; Kuroki, Lindsay; McCourt, Carolyn; Hagemann, Andrea R; Thaker, Premal; Mutch, David; Powell, Matthew; Hagemann, Ian S; Ilagan, Ma Xenia G; Fuh, Katherine; Verma, Priyanka; Schärer, Orlando D; Mosammaparast, Nima; Khabele, Dineo; Mullen, Mary M